Total planned funding: $160,616,136
Allocations
Countries/Regions
India | $160,616,136 |
Organizational Types
Unknown | $57,988,036 |
NGO | $51,909,099 |
Own Agency | $25,914,309 |
University | $15,932,112 |
Private Contractor | $3,348,272 |
Multi-lateral Agency | $2,856,808 |
FBO | $1,100,000 |
Host Country Government Agency | $940,200 |
Other USG Agency | $627,300 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $63,647,945 |
Prevention | $37,767,956 |
Care | $20,039,007 |
Management and Operations | $18,883,042 |
Treatment | $8,048,810 |
Testing | $7,801,584 |
Budget Codes
OHSS: Health Systems Strengthening | $38,114,043 |
HVSI: Strategic Information | $20,756,940 |
HVOP: Sexual Prevention: Other Sexual Prevention | $20,126,088 |
HVMS: Management and Operations | $18,883,042 |
HBHC: Care: Adult Care and Support | $12,697,323 |
HVCT: Testing: HIV Testing and Counseling | $7,801,584 |
HTXS: Treatment: Adult Treatment | $7,713,539 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,506,225 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,205,921 |
HLAB: Laboratory Infrastructure | $4,776,962 |
HKID: Care: Orphans and Vulnerable Children | $4,492,184 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,405,455 |
HMBL: Biomedical Prevention: Blood Safety | $2,514,267 |
HVTB: Care: TB/HIV | $2,368,193 |
PDCS: Care: Pediatric Care and Support | $481,307 |
PDTX: Treatment: Pediatric Treatment | $311,794 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$57,363,547
Countries/Regions
FHI 360:
$17,891,011
Countries/Regions
USG Aggregated Agencies:
$12,771,827
Countries/Regions
Voluntary Health Services:
$9,660,000
Countries/Regions